phase 2_3_completion
saveFaculty of Medicine Siriraj Hospital Mahidol University — bevacizumab (Phase II/III Trial Completion)
community read0 votes
Therapy area: Non Malignant Disorders. Indication: Hemangiomas
Data sources
globaldata
Found something off?
drug timeline · 4
- phase 1 completionUniversity of Texas MD Anderson Cancer Center — bevacizumab (Phase I Trial Completion)Apr 30, 2026 · 155d ago
- phase 1 2 completionIRCCS Foundation National Cancer Institute — bevacizumab (Phase I/II Trial Completion)Apr 30, 2026 · 155d ago
- phase 1 2 initiationBeijing Bethune Charitable Foundation — bevacizumab (Phase I/II Trial Initiation)Apr 30, 2026 · 155d ago
- phase 2 completionUniversity Health Network — bevacizumab (Phase II Trial Completion)Apr 24, 2026 · 161d ago
related news · 3
🐶 often sniffed alongside
top 8- tagOncology11 co-mentions · 4 sources
- tagRecall6 co-mentions · 4 sources
- drugGP-25 co-mentions · 3 sources
- drugbevacizumab biosimilar5 co-mentions · 3 sources
- tagColorectal Cancer3 co-mentions · 2 sources
- companyIRCCS Foundation National Cancer Institute1 co-mentions · 1 sources
- companyBeijing Bethune Charitable Foundation1 co-mentions · 1 sources
- companyUniversity of Texas MD Anderson Cancer Center1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that